|Dr. Eric Sun is currently in the School of Physical & Mathematical Sciences, Division of Chemistry & Biological Chemistry since 2006. He received his Bachelor degree in Chemistry from California State University – Chico, and Ph.D. degree from the University of Wisconsin – Madison (1979). He did his postdoctoral research in organic chemistry at MIT. Dr. Sun started his career in 1981 as a Senior Research Chemist with Monsanto Co in the US. He stayed with Monsanto’s pharmaceutical division until 1992 when he joined a drug discovery company Amylin in San Diego, California. He later joined a start-up company Alanex Corp which subsequently was acquired by Pfizer Inc. He held the position of group leader in medicinal chemistry in Pfizer Global R&D – La Jolla Labs from 2000 – 2003. During his career in the US, he was involved in drug discovery programs for the treatment of CNS diseases, AIDS, metabolic diseases, and cancer; and his responsibilities span from lead discovery to preclinical development.
Dr. Sun joined S*BIO as Head of Chemistry in 2003. From 2003 to 2006, he led a multi-disciplinary team of medicinal chemists and computational chemists in discovery and development of anti-cancer drugs. His research focus has been in discovery of novel inhibitors of Histone Deacetylases (HDACs) and inhibitors of Protein Kinases which act as targeted anti-tumor agents. Since May 2006, he has taken on the role of Senior Scientific Advisor in S*BIO. He has over 40 scientific publications and patents. Dr. Sun is a member of the American Chemical Society.